<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>While numerous cell-intrinsic processes are known to play decisive roles in chemotherapeutic response, relatively little is known about the impact of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> microenvironment on therapeutic outcome </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we use a well-established mouse model of Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> to show that paracrine factors in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> microenvironment modulate <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell survival following the administration of genotoxic chemotherapy </plain></SENT>
<SENT sid="2" pm="."><plain>Specifically, IL-6 and Timp-1 are released in the thymus in response to DNA damage, creating a "chemo-resistant niche" that promotes the survival of a minimal <z:e sem="disease" ids="C0543478" disease_type="Neoplastic Process" abbrv="">residual tumor</z:e> burden and serves as a reservoir for eventual <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> relapse </plain></SENT>
<SENT sid="3" pm="."><plain>Notably, IL-6 is released acutely from thymic endothelial cells in a p38-dependent manner following genotoxic stress, and this <z:hpo ids='HP_0011009'>acute</z:hpo> secretory response precedes the gradual induction of senescence in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-associated stromal cells </plain></SENT>
<SENT sid="4" pm="."><plain>Thus, conventional chemotherapies can induce <z:mp ids='MP_0010537'>tumor regression</z:mp> while simultaneously eliciting stress responses that protect subsets of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells in select anatomical locations from drug action </plain></SENT>
</text></document>